Pfenex (PFNX) Tops Q4 EPS by 13c, Revenues Miss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Oil slips as Saudi Arabia offers more crude via Oman
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
- Exclusive-SK Hynix in talks with Intel about deal to make memory chips in US for the first time, sources say
- Trade the FOMC: How stocks tend to perform on Fed hike days
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Shipping stocks on fire — but cracks are forming in the rate rally
- Bernstein on Crypto: 'Clarity fails - what next?'
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Pre-Open Stock Movers 03/07: (ARQL) (ALSK) (GWRE) Higher; (APVO) (BPI) (KR) Lower (more...)
March 7, 2019 9:26 AM ESTToday's Pre-Open Movers
Aptevo Therapeutics Inc. (Nasdaq: APVO) 43.2% LOWER; announced the pricing of (i) for a combined public offering price of $1.00 per share of common stock and related warrants, 19,850,000 shares of common stock and related warrants to purchase up to 19,850,000 shares of common stock at an exercise price of $1.30 per share, and (ii) for a combined public offering price of $0.99 per pre-funded warrant and related warrant, pre-funded warrants to purchase up to 2,150,000 shares of common stock at an exercise price of $0.01 per share and related warrants to... More
